Market Analysis - Autoimmunity-2017
Autoimmune Disease Therapeutics Market: Drivers and Restraints
Factors contributing to the growth of global autoimmune disease therapeutics market includes, growing prevalence of autoimmune diseases in worldwide coupled with growing public awareness and increasing automation of laboratories leading to diagnosis of several diagnostic tests simultaneously to generate rapid and error free results. In addition, technological advancements such as the development of novel biomarkers such as Enbrel and Humira, and portable diagnostic point of care equipment are further expected to fuel the market growth in the near future. However, factors such as, inadequate funding in developing countries, high cost involved in the treatment of the disease and non-availability of the treatment in developing countries along with emergence of alternative technologies are the main restraints for the global autoimmune disease therapeutics market.
Autoimmune Disease Therapeutics Market: Segmentation
Global autoimmune disease therapeutics market is segmented by drug class, distribution channeland geography as following:
· By Drug Class
· Anti-Inflammatory Drugs
· Nonsteroidal anti-inflammatory drugs
· By Distribution Channel
· Drug Stores
· Independent pharmacies
Autoimmune disease therapeutics Market: Overview
With rising incidence of autoimmune diseases, rapid technological advancements in medical field such as novel biomarkers, rise in healthcare expenditure, development and presence of large untapped opportunities in the emerging markets such as Eastern European, APAC and MEA region are major factors, expected to boost the growth of the global autoimmune disease therapeutics market during the forecast period (2016–2026).
Autoimmune Disease Therapeutics Market: Region-wise Outlook
Autoimmune Disease Diagnostics Market size is estimated to reach USD 15.7 billion by 2023; as per a new research report by Global Market Insights, Inc. Rising lab automation rates enabling faster and precise diagnosis in order to cater the increasing procedure volumes, and introduction of technologically advanced products should spur the global autoimmune disease diagnostics market size.
The global market for autoimmune disease therapeutics is expected to register a healthy CAGR during the forecast period. Depending on geographic regions, global autoimmune disease therapeutics market is segmented into seven key regions: North America, South America, Eastern Europe, Western Europe, Asia Pacific excluding Japan, Japan and Middle East & Africa.
Autoimmune disease therapeutics Market: Key Players
Some of the key market players in global autoimmune disease therapeutics market are
F. Hoffmann-La Roche AG,
Merck & Co. Inc.,
Bayer Schering Pharma AG,
Johnson & Johnson Inc.,
Biogen Idec Inc.,
Elan Corporation Plc,
Eli Lilly and Company,
Chugai Pharmaceutical Co. Ltd.
Other prominent vendors
Mitsubishi Tanabe Pharma
Swedish Orphan Biovitrum
The research report presents a comprehensive assessment of the market and contains thoughtful insights, facts, historical data, and statistically supported and industry-validated market data. It also contains projections using a suitable set of assumptions and methodologies. The research report provides analysis and information according to categories such as market segments, geographies, types, technology and applications.
Conference Series LLC invites all the participants from all over the world to attend International Conference on Autoimmunity November 09-10 at Madrid Spain. This includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.
Autoimmunity 2017 is to gathering people in academia and society interested in autoimmune disease and current research and shares the latest trends and important issues relevant to our field/subject area as its growing research and innovations in the scientific field. The scientific programme of the conference is broad and embraces different research aspects with focus mostly on autoimmune disease treatment and Immune system; the conference will include standard presentations, round table discussions, poster talks, panel discussions, and workshops.
Autoimmunity The great challenge for Researcher
Autoimmune diseases are a body’s hyperactive immune response against the substances and tissues normally present in the self-body. Autoimmune diseases are more commonly caused by genetic, infectious or environmental factors or mutations in the immune cells. The prevalence of autoimmune disease is on rise because many genetically changes accrue in next progeny. According to National Institute of Health, approximately 60 million of Americans suffer from autoimmune diseases. The diseases in estimated to be one of the top 07 cause of death in women under the age 65, and is the second highest cause of chronic illness. Also, it is the top cause of morbidity in women in the U.S. There are more than 90 clinically different type of autoimmune diseases identified till date. Some of the common types of autoimmune diseases are Crohn's disease, rheumatoid arthritis, inflammatory bowel disease, multiple sclerosis, systemic lupus erythematosus, and with rising prevalence of autoimmune diseases the demand of drugs used in the treatment for autoimmune disease is also rising
Who can attend our conference?
Doctors & Nurses
Associations and Societies
Manufacturing Medical Devices Companies
Directors of Association and Societies
How to Participate in Conference?
1. Speaker Participation:
A] Submit Your Abstract (Link: http://autoimmunity.conferenceseries.com/abstract-submission.php )
B] Registration (Link: http://autoimmunity.conferenceseries.com/registration.php )
2. Delegate directly goes for registration
(Link: http://autoimmunity.conferenceseries.com/registration.php )
Conference Main Topics & many related sub-topics
Cytokines and Current Research
Antibodies : Engineering and Therapeutics
Clinical Autoimmunity: Current & Future Research
Immune System and Autoimmunity
Autoimmunity in Women
Malignancy: The great Autoimmune Diseases
Allergy & Hypersensitivity
Immunometabolism and Autoimmunity
Arthritis, Ankylosing Spondylitis
Inflammation and diseases
HIV Drugs: Trigger of Autoimmunity